NEFL and amyotrophic lateral sclerosis: The levels of NfL were found to correlate with the progression of the disease, indicating that it could be a valuable biomarker for ALS (Sun et al., 2020; Dreger et al., 2021; Zhou et al., 2021; Thompson et al., 2022).